SEARCH

SEARCH BY CITATION

References

  • Ahlgren S. C. and Levine J. D. (1994) Protein kinase C inhibitors decrease hyperalgesia and C-fiber hyperexcitability in the streptozotocin-diabetic rat. J. Neurophysiol. 72, 684692.
  • Allouche W., Polastron J., Hasbi A., Homburer V. and Jauzac P. (1999) Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE. Biochem. J. 342, 7178.
  • Biessels G. and Gispen W. H. (1996) The calcium hypothesis of brain aging and neurodegenerative disorders: significance in diabetic neuropathy. Life Sci. 59, 379387.
  • Biessels G. J., Cristinno N. A., Rutten G. J., Hammers F. P., Erkelens D. W. and Gispen W. H. (1999) Neurophysiological changes in the central and peripheral nervous systems of the streptozotocin diabetic rat. Course of development and effects of insulin treatment. Brain Res. 122, 757768.
  • Birnbaumer L., Abramowitz T. and Brown A. M. (1990) Receptor-effector coupling by G proteins. Biochem. Biophys. Acta 1031, 163224.
  • Bischoff A. (1973) Ultrastructural pathology of peripheral nervous system in early diabetes, in Vascular and Neurological Changes in Early Diabetes, pp. 441449. Academic Press, New York.
  • Bornancin F. and Parker P. J. (1996) Phosphorylation of protein kinase C- on serine 657 controls the accumulation of active enzyme and contributes to its phosphatase-resistant state. J. Biol. Chem. 272, 35443549.
  • Bushfield M., Griffiths S. L., Murphy G. J., Pyne N. J., Knowler J. T., Milligan G., Parker P. J., Mollner S. and Houslay M. D. (1990) Diabetes-induced alterations in the expression, functioning and phosphorylation state of the inhibitory guanine nucleotide regulatory protein Gi2 in hepatocytes. Biochem. J. 271, 365372.
  • Cameron N. E., Cotter M. A., Jack A. M., Basso M. D. and Hohman T. C. (1999) Protein kinase C effects on nerve function, perfusion, Na+, K+-ATPase activity and glutathione content in diabetic rats. Diabetologia 42, 11201130.
  • Carter C. A. (2000) Protein kinase C as a drug target: implications for drug or diet prevention and treatment of cancer. Current Drug Targets 1, 163183.
  • Cesare P., Dekker L. V., Sardini A., Parker P. J. and McNaughton P. A. (1999) Specific involvement of PKC-ε in sensitization of the neuronal response to painful heat. Neuron 23, 617624.
  • De Waard M., Liu H., Walker D., Scott V. E. S., Gurnett C. A. and Campbell K. P. (1997) Direct binding of G-protein complex to voltage-dependent calcium channels. Nature 385, 446450.
  • Edwards A. S. and Newton A. C. (1997) Phosphorylation at conserved carboxyl-terminal hydrophobic motif regulates the catalytic and regulatory domains of protein kinase C. J. Biol. Chem. 272, 1838218390.
  • Garcia D. E., Li B., Garcia-Ferreiro R. E., Hernandez-Ochoa E. O., Yan K., Gautam N., Catterall W. A., Mackie K. and Hille B. (1998) G-protein beta-subunit specificity in the fast membrane-delimited inhibition of Ca2+ channels. J. Neurosci. 18, 91639170.
  • Greene D. A., Sima A. A. F., Stevens M. J., Feldman E. L. and Lattimer S. A. (1992) Diabetic complications: neuropathy and pathogenic considerations. Diabetes Care 15, 19021925.
  • Hall K. E., Sima A. A. F. and Wiley J. W. (1995) Voltage-dependent calcium currents are enhanced in rat dorsal root ganglion neurones from the Bio/Bred Worchester diabetic rat. J. Physiol. 486, 313322.
  • Hall K. E., Sima A. A. F. and Wiley J. W. (1996) Opiate-mediated inhibition of calcium signaling is decreased in DRG neurons from the diabetic BB/W rat. J. Clin. Invest. 97, 11651172.
  • Hall K. E., Liu J., Sima A. A. F. and Wiley J. W. (2001) Impaired inhibitory G-protein function contributes to increased calcium in rats with diabetic neuropathy. J. Neurophysiol. 86, 760770.
  • Huailing Z. and Neubig R. (2001) Regulator of G protein signaling: novel multifunctional drug targets. J. Pharmacol. Exp. Ther. 297, 837845.
  • Iiri T., Farfel Z. and Bourne H. R. (1998) G protein diseases furnish a model for the turn-on switch. Nature 394, 3538.
  • Katada T., Gilman A. G., Watanabe Y., Bauer S. and Jakobs K. H. (1985) Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase. Eur J. Biochem. 151, 431437.
  • Khasar S. G., Lin Y. H., Martin A., Dadgar J., McMahon T., Wang D., Hundle B., Aley K. D., Isenberg W., McCarter G. et al. (1999) A novel nociceptor signaling pathway revealed in protein kinase Cε mutant mice. Neuron 24, 253260.
  • Konishi H., Yamauchi E., Taniguchi H., Yamamoto T., Matsuzaki H., Takemura Y., Ohmae K., Kikkiwa U. and Nishizuka Y. (2001) Phosphorylation sites of protein kinase C δ in H2O2-treated cells and its activation by tyrosine kinase in vitro. Proc. Natl Acad. Sci. USA 98, 65876592.
  • Kozasa T. and Gilman A. G. (1996) Protein kinase C phosphorylates g12alpha and inhibits its interaction with gbetagamma. J. Biol. Chem. 271, 1256212567.
  • Levy J. and Gavin J. R. Jr III (1994) Diabetes mellitus: a disease of abnormal cellular calcium metabolism. Am. J. Med. 96, 260273.
  • Mathew J., Bianchi R., McLean W. G., Peterson R., Roberts R., Savaresi S. and Eichberg J. (1997) Phosphoinositide metabolism, Na,K-ATPase and protein kinase C are altered in peripheral nerve from Zucker diabetic fatty rats. Neurosci. Res. Comm. 20, 2130.
  • Morris N. J., Bushfield M., Lavan B. E. and Houslay M. D. (1996) Streptozotocin-induced diabetes elicits the phosphorylation of hepatocyte Gi2 at the protein kinase C but not at the protein kinase A-controlled site. Biochem. J. 315, 417420.
  • Nakamura J., Kato K., Hamada Y., Nakayama M., Chaya S., Nakashima E., Naruse K., Kasuya Y., Mizubayashi R., Miwa K. et al. (1999) Protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats. Diabetes 48, 20902095.
  • Nishikawa T., Edelstein D. and Brownlee M. (2000) The missing link: a single unifying mechanism for diabetic complications. Kidney Int. 58, S26S30.
  • Ohsawa M., Mizoguchi H., Narita M., Kamei J., Nagase H. and Tseng L. F. (1999) Effects of a mu-opioid receptor agonist on G-protein activation in streptozocin-induced diabetic mice. Eur. J. Pharmacol. 401, 5558.
  • Pieper G. M., Mizoguchi H., Ohsawa M., Kamei J., Nagase H. and Tseng L. F. (2000) Decreased opioid-induced antinociception but unaltered G-protein activation in the genetic-diabetic NOD mouse. Eur. J. Pharmacol. 401, 375379.
  • Roberts R. E. and Mclean W. G. (1997) Protein kinase C isozyme expression in sciatic nerves and spinal cords of experimentally diabetic rats. Brain Res. 754, 147156.
  • Sakaue Y., Sanada M., Sasaki T., Kashiwagi A. and Yasuda H. (2003) Amelioration of retarded neurite outgrowth of the dorsal root ganglion neurons by over expression of PKCδ in diabetic rats. Neuroreport 14, 431436.
  • Simonds W. F. (1999) G protein regulation of adenylate cyclase. TIPS 20, 6673.
  • Srinivasan S., Stevens M. and Wiley J. W. (2000) Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 49, 19321938.
  • Stariha R. L. and Kim S. U. (2001) Protein kinase C and mitogen-activate protein kinase signaling in oligodendrocytes. Micros.Res. Tech. 52, 680688.
  • Stevens M. J., Dananberg J., Feldman E. L., Lattimer S. A., Kamijo M., Thomas T. P., Shindo H., Sima A. A. and Green D. A. (1994) The linked roles of nitric oxide, aldose reductase, and (Na+, K+)-ATPase in slowing of nerve conduction in the streptozotocin diabetic rat. J. Clin. Invest. 94, 853859.
  • Tovey K. C., Oldham K. G. and Whelan J. A. M. (1974) A simple direct assay for cyclic AMP in plasma and other biological samples using an improved competitive protein binding technique. Clin. Chim. Acta 56, 221234.
  • Voitenko N. V., Kruglikov I. A., Kostyuk E. P. and Kostyuk P. G. (2000) Effect of streptozotocin-induced diabetes on the activity of calcium channels in rat dorsal horn neurons. Neuroscience 95, 519524.
  • Ways D. K. and Sheetz M. J. (2001) The role of protein kinase C in the development of the complications of diabetes. Vitam. Horm. 60, 149193.
  • Xie C. W. and Lewis D. V. (1997) Involvement of cAMP-dependent protein kinase in mu-opioid modulation of NMDA-mediated synaptic currents. J. Neurophysiol. 78, 759766.